Franklin Resources
ALDX icon

Franklin Resources’s Aldeyra Therapeutics ALDX Stock Holding History

Franklin Resources’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,346
Closed -$186K – 3028
2025
Q1 		$186K Buy
+32,346
New +$191K ﹤0.01% 2698

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources's ALDX Position: Q2 2025 in Review

Franklin Resources sold out of Aldeyra Therapeutics (ALDX) in Q2 2025, closing a stake of 32,346 shares — an estimated $186K sold.

Franklin Resources first reported a position in ALDX in Q1 2025 and held it in 1 quarter. The position peaked at $186K in Q1 2025. 121 funds tracked by Wall St. Rank hold ALDX as of Q2 2025.

  • Franklin Resources reported no remaining Aldeyra Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Franklin Resources sold 32,346 Aldeyra Therapeutics shares in Q2 2025, an estimated $186K.
  • Franklin Resources first reported a position in Aldeyra Therapeutics in Q1 2025 and held it in 1 quarter.
  • Franklin Resources's Aldeyra Therapeutics position peaked at $186K in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2025.

Based on Franklin Resources's 13F filing for Q2 2025, filed 12 Aug 2025.